Proteomic profiling of formalin-fixed paraffin-embedded specimens reveals candidate intraoperative diagnostic biomarkers for Hirschsprung disease
This study utilized proteomic profiling of formalin-fixed paraffin-embedded tissues to identify four novel candidate biomarkers (CTNNA2, EPDR1, NACAD, and NCAM2) that are specifically expressed in ganglionic regions, offering promising tools for the intraoperative diagnosis of Hirschsprung disease.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
In the world of pediatric surgery, some conditions are so rare that studying them feels like trying to map a single island in a vast, empty ocean. One such condition is Hirschsprung disease, a congenital disorder where a baby is born without the nerve cells that tell the lower intestine to move waste forward. Without these cells, the bowel becomes blocked, and the only cure is surgery to remove the diseased section and connect the healthy intestine to the anus. The critical challenge for surgeons is knowing exactly where the healthy tissue ends and the diseased tissue begins. If they leave even a small piece of the diseased section behind, the surgery fails; if they remove too much healthy tissue, the child suffers unnecessary loss. Traditionally, doctors rely on looking at tissue samples under a microscope during the operation, but this is difficult and not always precise, especially because the transition zone between healthy and diseased tissue can be subtle and hard to distinguish.
To solve this, a team of researchers turned to a resource that has been sitting in storage for decades: archived tissue samples preserved in wax. These samples, known as formalin-fixed paraffin-embedded tissues, are the standard way hospitals save specimens after surgery. While they have been used for decades to study cancer in adults, they have rarely been used to hunt for new clues in rare childhood diseases. The researchers asked a simple question: if they could read the molecular "fingerprint" of these old wax-embedded samples, could they find specific proteins that act as a clear signal for healthy nerve tissue? By analyzing the chemical makeup of these samples, they hoped to find a biological marker that surgeons could use to instantly recognize healthy bowel during an operation, removing the guesswork from the procedure.
The team focused on fifteen children who had undergone surgery for Hirschsprung disease. They gathered forty-five tissue samples from these patients, taking pieces from three distinct areas: the healthy intestine, the diseased section lacking nerve cells, and the tricky middle ground where the two meet. Using a highly sensitive technique that breaks down proteins into tiny fragments to identify them, the researchers examined the molecular content of these samples. They successfully identified over ten thousand different proteins. When they compared the healthy tissue against the diseased and transitional areas, they found a distinct pattern. While most of the protein differences were subtle and varied from child to child, thirteen specific proteins stood out as being significantly more abundant in the healthy intestine than in the areas lacking nerve cells.
Among these thirteen, four proteins were particularly interesting because they had never before been linked to Hirschsprung disease or the development of the gut. These were catenin alpha-2, mammalian ependymin-related protein 1, NAC-alpha domain-containing protein 1, and neural cell adhesion molecule 2. To confirm that these proteins were truly reliable indicators, the researchers performed a visual test on the tissue samples. They used special stains that would light up only if these specific proteins were present. The results were clear and consistent: all four proteins appeared brightly in the healthy parts of the intestine where nerve cells were present, but they were completely absent or barely visible in the diseased sections and the transitional zones. This confirmed that these proteins are tightly linked to the presence of healthy nerve cells.
The study also looked at the broader picture of what these proteins were doing. By grouping the proteins into functional categories, the researchers found that the healthy intestine was rich in molecules associated with building and maintaining nerve connections. This aligns perfectly with what is known about the disease, as the core problem in Hirschsprung disease is the absence of these very nerve cells. The findings suggest that the molecular signature of the healthy bowel is distinct and detectable, even in old, preserved samples.
While the results are promising, the researchers are careful to note that this is a preliminary step. The study involved a small number of patients, reflecting the rarity of the condition, and the analysis was done on stored samples rather than during actual surgery. The team did not test these markers in a live operating room setting, so their immediate clinical use is not yet established. However, the work demonstrates that it is possible to extract high-quality molecular data from archived wax-embedded tissues without needing new, invasive procedures on children. The identification of these four specific proteins offers a new set of candidates for future testing. If further studies can validate these markers in real-time surgical settings, they could eventually provide surgeons with a precise biological tool to distinguish healthy tissue from diseased tissue, ensuring that every child receives the exact amount of surgery they need.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.